Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 7/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.39 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | HPGD | P15428 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6629994 | 0.78 | ALDH1A1 (0.41) | NPSR1HIF1AEPAS1KDM4EMAPT | |
| SCHEMBL8690517 | 0.73 | HIF1A (0.39) | HIF1AEPAS1KDM4EALDH1A1HPGD | |
| SCHEMBL8692679 | 0.73 | HIF1A (0.39) | HIF1AEPAS1KDM4EALDH1A1HPGD | |
| SCHEMBL8690519 | 0.73 | HIF1A (0.39) | HIF1AEPAS1KDM4EALDH1A1HPGD | |
| SCHEMBL8689317 | 0.69 | ALDH1A1 (0.55) | NPSR1HIF1AEPAS1KDM4EALDH1A1 | |
| SCHEMBL8689922 | 0.69 | ALDH1A1 (0.55) | NPSR1HIF1AEPAS1KDM4EALDH1A1 | |
| SCHEMBL8692709 | 0.69 | ALDH1A1 (0.55) | NPSR1HIF1AEPAS1KDM4EALDH1A1 | |
| SCHEMBL7102356 | 0.69 | ALDH1A1 (0.55) | NPSR1HIF1AEPAS1KDM4EALDH1A1 | |
| SCHEMBL8689176 | 0.68 | HIF1A (0.35) | HIF1AEPAS1KDM4EALDH1A1HPGD | |
| SCHEMBL6690572 | 0.68 | CA12 (0.53) | NPSR1KDM4EMAPTALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1379529-A2 | PYRANOCOUMARIN COMPOUNDS AS A NOVEL PHARMACOPHORE WITH ANTI-TB ACTIVITY | Sarawak Medichem Pharmaceuticals, Inc. (US) | 2004-01-14 | — | — | EP | disclosed |
| US-6670383-B2 | Such as 5-(2-hydroxy-ethoxy)-2,2-dimethyl-6-propionyl-10-propyl-2H-pyrano(2,3 -f)chromen-8-one for treatment of Mycobacterium infection, AIDS, and tuburculosis | ADVANCED LIFE SCIENCES, INC. | 2003-12-30 | — | — | US | disclosed |
| US-20030083369-A1 | Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity | THE LEADERS BANK | 2003-05-01 | — | — | US | disclosed |
| WO-2002074777-A2 | PYRANOCOUMARIN COMPOUNDS AS A NOVEL PHARMACOPHORE WITH ANTI-TB ACTIVITY | SARAWAK MEDICHEM PHARMACEUTICALS, INC. (US) | 2002-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083369-A1 | Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity | BBOX1, CYP51A1, HADHB | NPSR1 4787/4885HIF1A 3504/4885EPAS1 2937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.